Astellas Middle East and Africa (MEA), a subsidiary of Astellas Pharma Inc. was established in November 2014. With our regional headquarters based in Dubai, United Arab Emirates, we aim to support better outcomes for patients across the region by improving access to our portfolio of innovative pharmaceutical solutions in Oncology, Haematology and Nephrology.
We are driven by our company-wide ethos of CHANGING TOMORROW™. Our incredibly talented teams of approximately 190 professionals, bring regional and global expertise that enables us to better understand our culturally diverse and dynamic environment. At Astellas, we are relentless in our pursuit of scientific progress and committed to tackling unmet medical needs.
Read more about Our Commitment
